{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:23:13Z","timestamp":1786980193305,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,11,14]],"date-time":"2009-11-14T00:00:00Z","timestamp":1258156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s00432-009-0702-5","type":"journal-article","created":{"date-parts":[[2009,11,13]],"date-time":"2009-11-13T07:13:49Z","timestamp":1258096429000},"page":"651-657","source":"Crossref","is-referenced-by-count":30,"title":["Macrophage migration inhibitory factor expression in cervical cancer"],"prefix":"10.1007","volume":"136","author":[{"given":"Mathias","family":"Krockenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg B.","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Dombrowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian F. M.","family":"H\u00e4usler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Kohrenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Dietl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Wischhusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnd","family":"Honig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,14]]},"reference":[{"key":"702_CR1","doi-asserted-by":"crossref","unstructured":"Agarwal R, Whang DH, Alvero AB Visintin I, Lai Y, Segal EA, Schwartz P, Ward D, Rutherford T, Mor G (2007) Macrophage migration inhibitory factor expression in ovarian cancer. Am J Obstet Gynecol 196:348.e1-e5","DOI":"10.1016\/j.ajog.2006.12.030"},{"issue":"16","key":"702_CR2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/newbio230246a0","volume":"230","author":"H Bartfeld","year":"1971","unstructured":"Bartfeld H, Atoynatan T (1971) Activity and properties of macrophage migration inhibitory factor produced by mixed lymphocyte cultures. Nat New Biol 230(16):246\u2013247","journal-title":"Nat New Biol"},{"key":"702_CR3","doi-asserted-by":"crossref","first-page":"13408","DOI":"10.1073\/pnas.0701553104","volume":"104","author":"I Binsky","year":"2007","unstructured":"Binsky I, Haran M, Starlets D, Gore Y, Lantner F, Harpaz N, Leng L, Goldenberg DM, Shvidel L, Berrebi A, Bucala R, Shachar I (2007) IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc Natl Acad Sci USA 104:13408\u201313413","journal-title":"Proc Natl Acad Sci USA"},{"key":"702_CR4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12253-008-9002-7","volume":"14","author":"H Camlica","year":"2008","unstructured":"Camlica H, Duranyildiz D, Oguz H, Oral EN, Yasasever V (2008) The diagnostic value of macrophage migration inhibitory factor (MIF) in gastric cancer. Pathol Oncol Res 14:79\u201383","journal-title":"Pathol Oncol Res"},{"key":"702_CR5","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.4049\/jimmunol.181.4.2330","volume":"181","author":"AM Coleman","year":"2008","unstructured":"Coleman AM, Rendon BE, Zhao M, Qian MW, Bucala R, Xin D, Mitchell RA (2008) Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, d-dopachrome tautomerase. J Immunol 181:2330\u20132337","journal-title":"J Immunol"},{"key":"702_CR6","doi-asserted-by":"crossref","first-page":"9354","DOI":"10.1073\/pnas.1533295100","volume":"100","author":"G Fingerle-Rowson","year":"2003","unstructured":"Fingerle-Rowson G, Petrenko O, Metz CN, Forsthuber TG, Mitchell R, Huss R, Moll U, M\u00fcller W, Bucala R (2003) The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci USA 100:9354\u20139359","journal-title":"Proc Natl Acad Sci USA"},{"key":"702_CR7","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4049\/jimmunol.175.2.1197","volume":"175","author":"T Hagemann","year":"2005","unstructured":"Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, Klemm F, Pukrop T, Binder C, Balkwill FR (2005) Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol 175:1197\u20131205","journal-title":"J Immunol"},{"key":"702_CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/bmj.39399.642894.AD","volume":"336","author":"RM James","year":"2008","unstructured":"James RM, Cruickshank ME, Siddiqui N (2008) Guideline Development Group. Management of cervical cancer: summary of SIGN guidelines. BMJ 336:41\u201343","journal-title":"BMJ"},{"key":"702_CR9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics. CA Cancer J Clin 58:71\u201396","journal-title":"CA Cancer J Clin"},{"key":"702_CR10","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.4049\/jimmunol.180.11.7338","volume":"180","author":"M Krockenberger","year":"2008","unstructured":"Krockenberger M, Dombrowski Y, Weidler C, Ossadnik M, H\u00f6nig A, H\u00e4usler S, Voigt H, Becker JC, Leng L, Steinle A, Weller M, Bucala R, Dietl J, Wischhusen J (2008) Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D. J Immunol 180:7338\u20137348","journal-title":"J Immunol"},{"key":"702_CR11","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1309\/GFCLLRH8A68XKMJN","volume":"129","author":"H Lee","year":"2008","unstructured":"Lee H, Rhee H, Kang HJ, Kim HS, Min BS, Kim NK, Kim H (2008) Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas. Am J Clin Pathol 129:772\u2013779","journal-title":"Am J Clin Pathol"},{"key":"702_CR12","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1200\/JCO.2006.09.3781","volume":"25","author":"HJ Long 3rd","year":"2007","unstructured":"Long HJ 3rd (2007) Management of metastatic cervical cancer: review of the literature. J Clin Oncol 25:2966\u20132974","journal-title":"J Clin Oncol"},{"key":"702_CR13","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1038\/sj.onc.1210318","volume":"26","author":"H Lue","year":"2007","unstructured":"Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, L\u00fcscher B, Bernhagen J (2007) Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5\/JAB1 in the control of autocrine MIF activity. Oncogene 26:5046\u20135059","journal-title":"Oncogene"},{"key":"702_CR14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.gene.6364427","volume":"8","author":"KL Meyer-Siegler","year":"2007","unstructured":"Meyer-Siegler KL, Vera PL, Iczkowski KA, Bifulco C, Lee A, Gregersen PK, Leng L, Bucala R (2007) Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes Immun 8:646\u2013652","journal-title":"Genes Immun"},{"key":"702_CR15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cellsig.2003.07.002","volume":"16","author":"RA Mitchell","year":"2004","unstructured":"Mitchell RA (2004) Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 16:13\u201319","journal-title":"Cell Signal"},{"key":"702_CR16","first-page":"253","volume":"15","author":"M Muramaki","year":"2006","unstructured":"Muramaki M, Miyake H, Yamada Y, Hara I (2006) Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression. Oncol Rep 15:253\u2013257","journal-title":"Oncol Rep"},{"key":"702_CR17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2007.08.089","volume":"108","author":"BS Nedergaard","year":"2008","unstructured":"Nedergaard BS, Ladekarl M, Nyengaard JR, Nielsen K (2008) A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5\u00a0years. Gynecol Oncol 108:106\u2013111","journal-title":"Gynecol Oncol"},{"key":"702_CR18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4049\/jimmunol.108.2.494","volume":"108","author":"PS Papageorgiou","year":"1972","unstructured":"Papageorgiou PS, Henley WL, Glade PR (1972) Production and characterization of migration inhibitory factor(s) (MIF) of established lymphoid and non-lymphoid cell lines. J Immunol 108:494\u2013504","journal-title":"J Immunol"},{"key":"702_CR19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.molcel.2004.11.052","volume":"17","author":"O Petrenko","year":"2005","unstructured":"Petrenko O, Moll UM (2005) Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway. Mol Cell 17:225\u2013236","journal-title":"Mol Cell"},{"key":"702_CR20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijc.11287","volume":"107","author":"Y Ren","year":"2003","unstructured":"Ren Y, Tsui HT, Poon RT, Ng IO, Li Z, Chen Y, Jiang G, Lau C, Yu WC, Bacher M, Fan ST (2003) Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int J Cancer 107:22\u201329","journal-title":"Int J Cancer"},{"key":"702_CR21","doi-asserted-by":"crossref","unstructured":"Rendon BE, Roger T, Teneng I, Zhao M, Al-Abed Y, Calandra T, Mitchell RA (2007) Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem 12:282(41):29910\u201329918","DOI":"10.1074\/jbc.M704898200"},{"key":"702_CR22","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1158\/1078-0432.1050.11.3","volume":"11","author":"B Sun","year":"2005","unstructured":"Sun B, Nishihira J, Yoshiki T, Kondo M, Sato Y, Sasaki F, Todo S (2005) Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway. Clin Cancer Res 11:1050\u20131058","journal-title":"Clin Cancer Res"},{"key":"702_CR23","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/ijc.23733","volume":"123","author":"S Textor","year":"2008","unstructured":"Textor S, D\u00fcrst M, Jansen L, Accardi R, Tommasino M, Trunk MJ, Porgador A, Watzl C, Gissmann L, Cerwenka A (2008) Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. Int J Cancer 123:2343\u20132353","journal-title":"Int J Cancer"},{"key":"702_CR24","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1053\/j.gastro.2005.07.061","volume":"129","author":"JM Wilson","year":"2005","unstructured":"Wilson JM, Coletta PL, Cuthbert RJ, Scott N, MacLennan K, Hawcroft G, Leng L, Lubetsky JB, Jin KK, Lolis E, Medina F, Brieva JA, Poulsom R, Markham AF, Bucala R, Hull MA (2005) Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology 129:1485\u20131503","journal-title":"Gastroenterology"},{"issue":"18","key":"702_CR25","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1158\/0008-5472.CAN-07-6227","volume":"68","author":"M Winner","year":"2008","unstructured":"Winner M, Meier J, Zierow S, Rendon BE, Crichlow GV, Riggs R, Bucala R, Leng L, Smith N, Lolis E, Trent JO, Mitchell RA (2008) A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells. Cancer Res 68(18):7253\u20137257","journal-title":"Cancer Res"},{"key":"702_CR26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.canlet.2007.11.028","volume":"261","author":"X Xu","year":"2008","unstructured":"Xu X, Wang B, Ye C, Yao C, Lin Y, Huang X, Zhang Y, Wang S (2008) Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett 261:147\u2013157","journal-title":"Cancer Lett"},{"key":"702_CR27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/01485010600630124","volume":"52","author":"DS Yu","year":"2006","unstructured":"Yu DS, Hsieh DS, Chang SY (2006a) Increasing expression of GST-pi MIF, and ID1 genes in chemoresistant prostate cancer cells. Arch Androl 52:275\u2013281","journal-title":"Arch Androl"},{"key":"702_CR28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/01485010600630116","volume":"52","author":"DS Yu","year":"2006","unstructured":"Yu DS, Lin JC, Hsieh DS, Chang SY, Lee CF (2006b) Modulation of MDR-1 gene by MIF and GSTpi with drug resistance generation in hormone independent prostate cancer. Arch Androl 52:283\u2013291","journal-title":"Arch Androl"},{"key":"702_CR29","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.4049\/jimmunol.181.3.1877","volume":"181","author":"Q Zhou","year":"2008","unstructured":"Zhou Q, Yan X, Gershan J, RJ Orentas, BD Johnson (2008) Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo. J Immunol 181:1877\u20131886","journal-title":"J Immunol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-009-0702-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-009-0702-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-009-0702-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T10:45:28Z","timestamp":1685184328000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-009-0702-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,14]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["702"],"URL":"https:\/\/doi.org\/10.1007\/s00432-009-0702-5","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,14]]}}}